NEWS FEED & ADDITIVE MAGAZINE March 2024 97 PetWise, Inc., one of the leading providers of solution-based pet products, announced that E. McDowell “Mac” Tillman has been named Chief Executive Officer. As part of this appointment, Kevin Fick, who has served as CEO of PetWise since 2012, has been elevated to a new role with the company’s coard of directors, where he will continue to work with Tillman and the company. Mac Tillman brings to PetWise more than 25 years of enterprise-level experience leading high-performing teams and driving brand growth in the consumer product goods and pet care industries. Tillman held pivotal roles at Big Heart Pet Brands and Del Monte Foods, and was most recently the CEO of Alete Active Nutrition, which he helped grow from one to four brands, tripling annual revenue in just three years. Earlier in his career, Tillman held senior"-level positions at CamelBak and Timberland, having started his career with Procter & Gamble. Prior to the corporate world, Tillman served honourably as a Major in the United States Marine Corps, having earned his B.S. in General Engineering from the U.S. Naval Academy. Tillman also holds an MBA from Cornell University. “PetWise has a 30-year legacy of nurturing the special bond between pets and their families,” said Mac Tillman. “In this new role, my focus will be to deepen those meaningful connections through innovative products and engaging brand experiences that are unique to PetWise’s offerings. This is an exciting time to be joining this organization, and I am eager to collaborate with our talented team to chart a course together for our next phase of growth and market leadership.” Read more>> PetWise appoints Mac Tillman as CEO Mac Tillman In a bid to revolutionize aquaculture research and drive innovation in sustainable seafood production, The Center for Aquaculture Technologies Canada (CATC), one of the pioneering leaders in aquaculture contract research, announced its new Tenacibaculosis Challenge Model. Aquaculture plays a critical role in meeting the world’s growing demand for seafood while alleviating pressure on wild fish populations. The industry faces numerous challenges, however, including disease outbreaks. According to the Norway Veterinary Institute, 62.7 million farmed salmon died in the sea phase in Norway alone in 2023, corresponding to a staggering 16.7% of farmed salmon released. CATC’s new Tenacibaculosis Challenge Model is designed to accelerate research into vaccines and feed additives for, or the identification of genetically resistant strains of, this major cause of cultured salmon mortality. While antibiotic treatments are occasionally used against Tenacibaculum, their effectiveness is variable, and no reliable prophylactic treatment currently exists. This Tenacibaculosis Challenge Model aims to provide the necessary tools to alleviate this gap, pulling the industry forward and away from a vulnerable position. Leveraging state-of-the-art technology & facilities, unparalleled expertise, and a relentless pursuit of excellence, this innovative model promises to advance the pharma and feed sector in providing a range of solutions to salmon farmers globally. According to CATC, the Tenacibaculosis Challenge Model represents a groundbreaking approach to tackling the obstacles of this disease head-on. As is always expected from CATC, bespoke services with this new challenge model are available, allowing customization to the outcome, goal, product, or client’s needs. Read more>> CATC introduces its new Tenacibaculosis Challenge Model
RkJQdWJsaXNoZXIy MTUxNjkxNQ==